DSIJ Mindshare

Back-to-Back Upper Circuit Stock: This Small-cap Stock Locked in 2 Per Cent Upper Circuit; Stock Hits 21-Day Winning Streak With Strong Healthcare Expansion Push
DSIJ Intelligence-2

Back-to-Back Upper Circuit Stock: This Small-cap Stock Locked in 2 Per Cent Upper Circuit; Stock Hits 21-Day Winning Streak With Strong Healthcare Expansion Push

The stock has given multibagger returns over 400 per cent in last 12 months.

AAyush Wellness Ltd's share price locked in the 2 per cent upper circuit on Tuesday. In the latest development, the company has launched its first healthcare centre and smart health kiosks in Mumbai in Maharashtra, India. The company has installed a health ATM which will conduct diagnostics tests in a few minutes, maintain digital health records, and also facilitate telemedicine. The company plans to invest up to 250 million Indian rupees in the first phase of the planned expansion of its healthcare centres in India. 

DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, download the service details here.

Over the last 5 trading sessions, the stock has hit back-to-back upper circuit limits. Along with this, the stock price has made a winning streak of 21 trading sessions.  The stock has given multibagger returns of over 400 per cent in the last 12 months.

Incorporated in 1984, Aayush Wellness Ltd (AWL) is engaged in offering nutraceutical products, personalised healthcare services, preventive wellness programs, and digital health solutions. The company operates an integrated platform that allows individuals to access a variety of wellness and healthcare services tailored to their specific needs. These include online doctor consultations, nutritional support programs, and public health awareness campaigns.

AWL’s product portfolio features a combination of innovative health products. Among them, Aayush Herbal Pan Masala is aimed at offering a herbal alternative to reduce the intake of tobacco and supari. Dreamy Sleep Gummies are formulated to improve sleep quality and address sleep-related issues, while Beauty Vitamin Gummies promote healthy skin and hair through hydration and nourishment.

As part of its strategic investments, AWL announced the formation of a Strategic Growth Division on January 29, 2025, with a dedicated corpus of Rs 50 million. This division focuses on investing in startups and existing businesses that contribute to consumer well-being.

AWL has also embarked on notable expansion plans. On April 26, 2025, it launched its first healthcare centre in Virar, Mumbai, featuring a Health ATM capable of conducting multiple diagnostic tests within minutes. This setup also includes digital health record maintenance and telemedicine support to detect and address potential health issues early. Additionally, on December 23, 2024, AWL announced its entry into the Wellness Tourism sector. The company plans to invest up to Rs 30 crore over the next two years in collaboration with governments, tourism boards, and private firms to offer wellness retreats and programs that blend traditional practices such as yoga and Ayurveda with modern wellness innovations. 

To support its global expansion, AWL established a wholly owned subsidiary named Aayush Worldwide Private Limited on January 7, 2025. This entity will lead the company’s entry into international markets through the export of wellness and nutraceutical products.

Disclaimer: The article is for informational purposes only and not investment advice.

 

Previous Article FIIs bought 97,63,222 shares: Penny stock under Rs 20; Company announces FY25 results; Reduced debt and approved raising funds via FCCBs
Next Article DIIs Bought 3,74,000 Shares: Food Products Company’s Stock in Green as It Approves Migrating from NSE Emerge (SME Platform) to Main Board
Print
126 Rate this article:
5.0
Please login or register to post comments.
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR